Chitosan and its derivatives as nanocarriers for siRNA delivery

被引:14
|
作者
Al-Qadi, S. [1 ]
Grenha, A. [2 ]
Remunan-Lopez, C. [1 ]
机构
[1] Univ Santiago de Compostela, Fac Pharm, Dept Pharm & Pharmaceut Technol, Nanobiofar Grp, Santiago De Compostela 15782, Spain
[2] Univ Algarve, IBB Inst Biotechnol & Bioengn, CBME Ctr Mol & Struct Biomed, Faro, Portugal
关键词
Chitosan; Chitosan derivatives; Formulation parameters; Gene silencing; Nanocarriers; siRNA delivery; SMALL INTERFERING RNA; TARGETED GENE DELIVERY; NUCLEIC-ACID DELIVERY; MOLECULAR-WEIGHT; IN-VITRO; DRUG-DELIVERY; ANTISENSE OLIGONUCLEOTIDES; ANTIINFLAMMATORY TREATMENT; NANOPARTICLE FORMULATION; INTRAVENOUS DELIVERY;
D O I
10.1016/S1773-2247(12)50003-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ability to specifically silence genes using siRNA has enormous potential for treating genetic diseases. However, siRNA instability and biodistribution issues still need to be overcome, and adequate delivery vehicles have proven indispensable in conveying siRNA to its target. Chitosan is a promising biopolymer for siRNA delivery, its interest stemming from its solely, biodegradability, mucoadhesivity, permeation enhancing effect and cationic charge, as well as amenability to undergo chemical modifications. Chitosan and its derivatives can be readily arranged into complexes or nanoparticles able to entrap and carry siRNA. Specific strategies have been adopted to improve chitosan-based vectors with regard to transfectability. However, further efforts cure required to verify their value and adapt them to enhance therapeutic output prior to clinical application. This review emphasizes the potential of chitosan and its derivatives to develop nanocarriers for siRNA delivery. The properties of chitosan that are significant for transfectability and the most relevant findings are assessed.
引用
收藏
页码:29 / 42
页数:14
相关论文
共 50 条
  • [31] Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents
    Zhao, Jing
    Feng, Si-Shen
    NANOMEDICINE, 2015, 10 (14) : 2199 - 2228
  • [32] Water-soluble substituted chitosan derivatives as technology platform for inhalation delivery of siRNA
    Capel, Victoria
    Vllasaliu, Driton
    Watts, Peter
    Clarke, Philip A.
    Luxton, Dominic
    Grabowska, Anna M.
    Mantovani, Giuseppe
    Stolnik, Snjezana
    DRUG DELIVERY, 2018, 25 (01) : 644 - 653
  • [33] Lipid-based Vehicles for siRNA Delivery in Biomedical Yield
    Li, Tianzhong
    Huang, Linfeng
    Yang, Mengsu
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2020, 21 (01) : 3 - 22
  • [34] Chitosan and its derivatives for gene delivery
    Lee, Kuen Yong
    MACROMOLECULAR RESEARCH, 2007, 15 (03) : 195 - 201
  • [35] Chitosan and its derivatives for gene delivery
    Kuen Yong Lee
    Macromolecular Research, 2007, 15 : 195 - 201
  • [36] Nebulised siRNA encapsulated crosslinked chitosan nanoparticles for pulmonary delivery
    Sharma, Ketan
    Somavarapu, Satyanarayana
    Colombani, Agnes
    Govind, Nayna
    Taylor, Kevin M. G.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 455 (1-2) : 241 - 247
  • [37] Chitosan nanocarriers for microRNA delivery and detection: A preliminary review with emphasis on cancer
    Sargazi, Saman
    Siddiqui, Bazla
    Qindeel, Maimoona
    Rahdar, Abbas
    Bilal, Muhammad
    Behzadmehr, Razieh
    Mirinejad, Shekoufeh
    Pandey, Sadanand
    CARBOHYDRATE POLYMERS, 2022, 290
  • [38] siRNA Delivery Using Nanocarriers - An Efficient Tool for Gene Silencing
    Khurana, Bharat
    Goyal, Amit K.
    Budhiraja, Abhishek
    Arora, Daisy
    Vyas, Suresh P.
    CURRENT GENE THERAPY, 2010, 10 (02) : 139 - 155
  • [39] Polymeric Systems as Nanodevices for siRNA Delivery
    Tiera, Marcio J.
    Shi, Qin
    Goncalves Barbosa, Hellen Franciane
    Fernandes, Julio C.
    CURRENT GENE THERAPY, 2013, 13 (05) : 358 - 369
  • [40] Nanocarriers in effective pulmonary delivery of siRNA: current approaches and challenges
    Bardoliwala, Denish
    Patel, Vivek
    Javia, Ankit
    Ghosh, Saikat
    Patel, Akanksha
    Misra, Ambikanandan
    THERAPEUTIC DELIVERY, 2019, 10 (05) : 311 - 332